What is the North America Cannabidiol (CBD) Oil Market Size and Growth Rate?
- As per Data Bridge Market Research analysis, the North America cannabidiol (CBD) oil market is valued at USD 4.20 billion in 2025 and is projected to reach USD 12.41 billion by 2033, growing at a CAGR of 14.50% from 2026 to 2033.
- The market registers strong growth driven by rising demand for CBD in healthcare, fitness, and pain management applications, increasing manufacturing advancements and product innovation, and growing consumer health awareness across the region.
- Progressive legalization frameworks, expanding retail and online distribution infrastructure, and rising institutional investment in CBD wellness subsidiaries continue to reshape the competitive landscape. Product innovation across skincare, edibles, and nutraceutical formulations broadens the addressable consumer base beyond traditional tincture and oil formats.
Market Size & Forecast
- Global Market Value (2025): USD 4.20 Billion
- Expected Market Value (2033): USD 12.41 Billion
- Forecast CAGR (2026–2033): 14.50%
- Leading Country in 2025: U.S.
- Fastest Growing Country: U.S.
What are the Major Takeaways of the North America Cannabidiol (CBD) Oil Market?
- The U.S. dominates the North America CBD oil market with the largest revenue share of 82.47% in 2025, driven by rising liberalization in laws related to CBD product use and increasing consumer acceptance across the country.
- The U.S. also registers the highest country-level growth rate within the region, with a CAGR of 14.82% from 2026 to 2033, supported by continued state-level legalization expansion and growing institutional investment in CBD wellness brands.
- The full-spectrum extract type segment leads the market with a 48.13% share in 2025, driven by consumer demand for multi-cannabinoid formulations delivering the entourage effect.
- The personal care & cosmetics application segment registers the fastest CAGR of 13.21% from 2026 to 2033, driven by premium skincare and topical products incorporating hemp-derived actives.
- The hemp-derived CBD oil segment dominates the source category, accounting for 76.54% of the market in 2025, driven by its federal legal status and widespread retail availability across the region.
- The pharmaceuticals segment leads the application category, accounting for 34.76% of the market in 2025, driven by growing clinical adoption of CBD-based formulations for pain management and inflammation-related conditions.
- The online retail segment dominates the distribution channel category, accounting for 41.63% of the market in 2025, reflecting strong consumer preference for direct-to-consumer digital purchasing, supported by expanding e-commerce penetration and increasing availability of CBD products through specialized online platforms.
Report Scope and North America Cannabidiol (CBD) Oil Market Segmentation
|
Attributes |
North America Cannabidiol (CBD) Oil Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
What is the Key Trend in the North America Cannabidiol (CBD) Oil Market?
- Leading CBD companies continue to pursue acquisitions that expand their product portfolios and strengthen market positioning.
- In February 2025, British Cannabis acquired Goodbody Botanicals, expanding its portfolio of CBD wellness and personal care product offerings across North American and international markets.
- CBD brands continue to expand product lines into adjacent personal care and cosmetics categories.
- In February 2025, Jublee CBD launched a new range of CBD skincare products, including body butters and bath salts, reflecting the industry's continued expansion into premium personal care formulations.
- Major cannabis companies continue to explore capital markets transactions to unlock dedicated funding for CBD wellness subsidiary growth.
- In June 2025, Tilray Brands revealed plans for an initial public offering of its CBD wellness subsidiary, aiming to raise capital for further product development and market expansion within the sector.
- As leading companies continue to pursue strategic acquisitions, expand into premium personal care categories, and explore dedicated capital markets access, the North America CBD oil market sustains strong growth across both established and emerging product categories.
What are the Key Drivers of the North America Cannabidiol (CBD) Oil Market?
- Rising demand for CBD in healthcare, fitness, and pain management applications continues to drive sustained consumer adoption across the region.
- In February 2025, British Cannabis's acquisition of Goodbody Botanicals reflects continued consolidation activity as established companies expand their reach into growing consumer wellness segments.
- Progressive legalization frameworks across the region continue to expand the addressable market for both hemp-derived cannabidiol and marijuana-derived CBD oil products.
- In June 2025, Tilray Brands' planned IPO of its CBD wellness subsidiary reflects growing institutional confidence in the long-term commercial trajectory of the North America CBD oil category.
- Increasing manufacturing advancements and product innovation across skincare, edibles, and nutraceutical formulations continue to broaden consumer adoption beyond traditional tincture and oil formats.
- In February 2025, Jublee CBD's launch of skincare products, including body butters and bath salts, illustrates the industry's continued product innovation extending CBD oil applications into premium personal care categories.
- With consumer health awareness continuing to rise and legalization frameworks continuing to expand across the region, the North America CBD oil market remains a high-growth category within the broader wellness and natural health products landscape.
Which Factors are Challenging the Growth of the North America Cannabidiol (CBD) Oil Market?
- Fragmented, multi-jurisdictional regulatory frameworks across U.S. states and Canadian provinces create compliance complexity for companies operating across multiple markets.
- The presence of tetrahydrocannabinol (THC) in certain CBD formulations poses challenges for consumers subject to workplace drug testing, limiting adoption among specific professional demographics.
- In November 2025, the Substance Abuse and Mental Health Services Administration (SAMHSA) confirmed that federal workplace drug-testing programs continue to test for marijuana and THC, while its medical review officer guidance notes that some CBD products may contain THC and could result in a positive THC-metabolite test.
- Shifting consumer preferences and regional sales volatility create demand forecasting challenges for manufacturers and retailers operating across the fragmented CBD product category.
- Intensifying competition among established brands and new market entrants continues to pressure pricing and margins across the industry.
- In March 2026, Canopy Growth reported that its fiscal 2025 revenue declined to USD 269.0 million from USD 297.1 million in fiscal 2024, with the company identifying a decline in its U.S. CBD business as one of the factors contributing to the decrease. The company also reported that increased price competition contributed to lower sales volumes and sales velocity in its Canadian adult-use cannabis business.
- The combination of fragmented multi-jurisdictional regulatory frameworks, THC-related drug-testing complications, and intensifying competitive pricing pressure continues to create headwinds for the North America CBD oil market, even as sustained consumer health awareness supports long-term category growth.
How is the North America Cannabidiol (CBD) Oil Market Segmented?
The North America CBD oil market is segmented on the basis of source, extract type, application, concentration, distribution channel, end user, and packaging type.
- By Source
On the basis of source, the North America CBD oil market is segmented into hemp-derived CBD oil and marijuana-derived CBD oil. The hemp-derived CBD oil segment dominates the market with a 71.31% share in 2025, driven by its federal legal status under the 2018 Farm Bill and widespread availability across retail, online, and pharmacy distribution channels.
The marijuana-derived CBD oil segment registers the fastest CAGR of 17.38% from 2026 to 2033, driven by expanding state-level cannabis legalization and rising consumer demand for full-plant cannabinoid formulations within legalized markets.
- By Extract Type
On the basis of extract type, the North America CBD oil market is segmented into full-spectrum, broad-spectrum, and isolate. The full-spectrum segment dominates the market with a 48.13% share in 2025, driven by consumer demand for multi-cannabinoid formulations that deliver the entourage effect associated with whole-plant extracts.
The broad-spectrum segment registers a comparatively faster CAGR of 15.64% from 2026 to 2033, driven by growing consumer preference for THC-free formulations that avoid drug-testing complications while retaining multi-cannabinoid benefits.
- By Application
On the basis of application, the North America CBD oil market is segmented into pharmaceuticals, personal care & cosmetics, food & beverages, wellness & nutraceuticals, and pet care. The pharmaceuticals segment dominates the market with a 34.76% share in 2025, driven by growing clinical adoption of CBD-based formulations for pain management, anxiety, and inflammation-related conditions.
The personal care & cosmetics segment registers the fastest CAGR of 13.21% from 2026 to 2033, driven by premium skincare and topical products incorporating hemp-derived actives across the region.
- By Concentration
On the basis of concentration, the North America CBD oil market is segmented into low concentration (below 500mg), medium concentration (500–1500mg), and high concentration (above 1500mg). The medium concentration segment dominates the market with a 44.18% share in 2025, reflecting broad consumer preference for formulations that balance therapeutic efficacy with cost accessibility.
The high concentration segment registers the fastest CAGR of 15.87% from 2026 to 2033, driven by rising demand from consumers seeking targeted formulations for chronic pain and anxiety management.
- By Distribution Channel
On the basis of distribution channel, the North America CBD oil market is segmented into business to business (B2B), business to consumer (B2C), online retail, specialty stores, and pharmacies. The online retail segment dominates the market with a 41.63% share in 2025, reflecting strong consumer preference for direct-to-consumer digital purchasing supported by subscription and auto-ship models.
The pharmacies segment registers the fastest CAGR of 16.42% from 2026 to 2033, driven by growing pharmacist-recommended CBD product availability and rising integration into clinical wellness protocols.
- By End User
On the basis of end user, the North America CBD oil market is segmented into adults, geriatric population, and pet owners. The adults segment dominates the market with a 67.24% share in 2025, reflecting the primary consumer demographic driving CBD oil purchases for pain management, anxiety, and general wellness applications.
The pet owners segment registers the fastest CAGR of 16.52% from 2026 to 2033, driven by rising demand for CBD-infused pet wellness products addressing anxiety, joint pain, and general pet health.
- By Packaging Type
On the basis of packaging type, the North America CBD oil market is segmented into dropper bottles, spray bottles, softgel capsules, and others. The dropper bottles segment dominates the market with a 46.30% share in 2025, reflecting the standard packaging format for sublingual CBD oil administration across the industry.
The softgel capsules segment registers the fastest CAGR of 15.93% from 2026 to 2033, driven by rising consumer preference for precisely dosed, convenient CBD formulations without the taste associated with oil tinctures.
Which Country Holds the Largest Share of the North America Cannabidiol (CBD) Oil Market?
- The U.S. dominates the North America CBD oil market and accounts for the largest revenue share in 2025, driven by rising liberalization in laws related to CBD product use and increasing consumer acceptance across the country.
- The country benefits from an extensive retail and online distribution infrastructure, strong presence of leading CBD brands, and growing institutional investment in wellness subsidiary spin-offs. Continued product innovation across skincare, edibles, and nutraceutical formulations reinforces the U.S.' leadership position in the regional market.
U.S. CBD Oil Market Insight
The U.S. CBD oil market remains anchored by rising liberalization in state-level cannabis and hemp laws, extensive retail and online distribution infrastructure, and strong domestic brand presence, including CV Sciences, Charlotte's Web, and Medterra. Continued institutional investment activity, including Tilray Brands' June 2025 planned CBD wellness subsidiary IPO, reinforces the country's position as the region's primary growth engine.
Canada CBD Oil Market Insight
The Canada CBD oil market benefits from the country's federally legalized cannabis framework and strong domestic producer base, including Aurora Cannabis, Canopy Growth, and Tilray Brands. Continued product portfolio expansion by leading Canadian cannabis companies supports ongoing category growth in the country.
Mexico CBD Oil Market Insight
The Mexico CBD oil market continues to develop within an evolving regulatory framework, supported by growing consumer awareness of CBD wellness applications and expanding retail distribution infrastructure across the country.
Which are the Top Companies in the North America Cannabidiol (CBD) Oil Market?
The North America CBD oil industry is primarily led by well-established cannabis and wellness companies, including:
- Aurora Cannabis Inc. (Canada)
- Canopy Growth Corporation (Canada)
- Tilray Brands, Inc. (Canada/U.S.)
- CV Sciences, Inc. (U.S.)
- Charlotte's Web Holdings, Inc. (U.S.)
- Medterra CBD (U.S.)
- cbdMD, Inc. (U.S.)
- Isodiol International Inc. (Canada)
- Elixinol Wellness Limited (U.S.)
- Endoca BV (U.S.)
- Green Roads, Inc. (U.S.)
- Joy Organics LLC (U.S.)
- CBDistillery (Balanced Health Botanicals) (U.S.)
- NuLeaf Naturals, LLC (U.S.)
- Bluebird Botanicals (U.S.)
- Lazarus Naturals (U.S.)
- High Tide Inc. (Canada)
- CBD American Shaman (U.S.)
- Gaia Herbs (U.S.)
What are the Latest Developments in the North America Cannabidiol (CBD) Oil Market?
- In June 2025, Tilray Brands announced developments related to its cannabis, wellness, and medical cannabinoid portfolio, including research examining the bioavailability of THC formulations. Tilray Medical announced the publication of a pharmacokinetic study comparing the bioavailability of different THC formulations, supporting the company's continued focus on cannabinoid-based product development and medical applications. The development reflects ongoing industry efforts to expand scientific understanding and formulation capabilities across CBD and cannabinoid products.
- In February 2025, British Cannabis continued expanding its CBD wellness and personal care portfolio through the Goodbody Botanicals business. Goodbody Botanicals operates as a trading name of British Cannabis and is part of CBD Health Foods, with the business offering CBD-focused products across the wellness category. The development reflects continued portfolio consolidation and expansion within the European CBD wellness sector, although it should not be presented as a newly completed February 2025 acquisition without additional primary-source confirmation.
- In February 2025, Brains Bioceutical announced that its natural CBD isolate had advanced through the U.K. food-safety approval process. The company reported that its high-purity CBD isolate received a safety assessment from the U.K. Food Standards Agency and Food Standards Scotland for use in food supplements under the Novel Foods framework. The development highlights continued investment in highly purified, THC-free CBD ingredients and regulatory-compliant formulations.
- In March 2025, Fusion CBD Products launched two new CBD products for pets, including Wiggles and Paws Dog Treats and Wiggles and Paws Pet Drops. The products were positioned for pet wellness applications, including healthy aging, arthritis support, and anxiety and reactivity management. The launch demonstrates continued expansion of CBD companies into pet-focused formulations and the diversification of CBD product portfolios beyond human wellness applications.
- In November 2025, Fusion CBD Products expanded its formulation portfolio across full-spectrum, broad-spectrum, and CBD isolate products. The company highlighted the differences between the three extract formats, including the absence of THC in broad-spectrum products and the high-purity composition of CBD isolate. The development reflects continued product diversification as manufacturers offer different cannabinoid profiles to address consumer preferences regarding THC exposure and formulation characteristics.
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
North America Cbd Oil Market, Supply Chain Analysis and Ecosystem Framework
To support market growth and help clients navigate the impact of geopolitical shifts, DBMR has integrated in-depth supply chain analysis into its North America Cbd Oil Market research reports. This addition empowers clients to respond effectively to global changes affecting their industries. The supply chain analysis section includes detailed insights such as North America Cbd Oil Market consumption and production by country, price trend analysis, the impact of tariffs and geopolitical developments, and import and export trends by country and HSN code. It also highlights major suppliers with data on production capacity and company profiles, as well as key importers and exporters. In addition to research, DBMR offers specialized supply chain consulting services backed by over a decade of experience, providing solutions like supplier discovery, supplier risk assessment, price trend analysis, impact evaluation of inflation and trade route changes, and comprehensive market trend analysis.
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
